Non-deletional Hb H disease patients had compound heterozygous α0-thalassemia (--CR) with Hb CS, and presented with moderate to severe anemia and required regular blood transfusions (1–2 units) every 4–5 months. This evidence concerns the gene GSTM1 and anemia.